These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19494402)

  • 1. Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
    Shammas NW; Shammas G; Bryan D; Rauba J; Dippel E; Jerin M
    J Invasive Cardiol; 2009 Jun; 21(6):266-9. PubMed ID: 19494402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina.
    Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Aquilina M; Corlianò L; Saia F; Taglieri N; Sbarzaglia P; Bacchi Reggiani ML; Branzi A
    Ital Heart J; 2004 Mar; 5(3):189-96. PubMed ID: 15119501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gradual computerized angioplasty on outcomes of patients undergoing coronary stenting.
    Leibowitz D; Lotan C; Katz I; Nassar H; Boguslavsky L; Mosseri M; Jabara R; Varshitzsky B; Danenberg H; Weiss AT
    Am J Cardiol; 2009 Jul; 104(2):223-6. PubMed ID: 19576351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
    Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
    Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma leptin and prognosis in patients with established coronary atherosclerosis.
    Wolk R; Berger P; Lennon RJ; Brilakis ES; Johnson BD; Somers VK
    J Am Coll Cardiol; 2004 Nov; 44(9):1819-24. PubMed ID: 15519013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
    Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary angioplasty on calcified lesions].
    Alfonso F; Macaya C; Iñiguez A; Fernández-Ortiz A; Zarco P
    Rev Esp Cardiol; 1990 Apr; 43(4):231-8. PubMed ID: 2353122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute phase proteins and recurrence of angina after effective coronary angioplasty].
    Alekseeva IA; Liakishev AA; Tkachuk VA; Dobrovol'skiĭ AB; Nasonov EL; Naumov VG; Parfenova EV
    Ter Arkh; 2002; 74(4):42-5. PubMed ID: 12043237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital.
    Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA
    Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and clinical restenosis after coronary stent placement.
    Rana JS; Mittleman MA; Ho KK; Cutlip DE
    Am Heart J; 2005 Oct; 150(4):821-6. PubMed ID: 16209988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the adipose-tissue hormone resistin and coronary artery disease.
    Hoefle G; Saely CH; Risch L; Koch L; Schmid F; Rein P; Aczél S; Berchtold S; Drexel H
    Clin Chim Acta; 2007; 386(1-2):1-6. PubMed ID: 17706624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
    Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
    Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
    Bosevski M; Kostoska S; Tosev S; Borozanov V
    Angiol Sosud Khir; 2006; 12(2):9-15. PubMed ID: 17053757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.